Background Despite evidence that medications to treat opioid use disorder (OUD) are
effective, most people who could benefit from this treatment do not receive it. This rapid …

Even though evidence-based treatment for opioid use disorders (OUD) is effective, almost
four in five Americans with OUD do not receive any form of treatment. The gap in access to …

On October 30 and 31, 2018, the Committee on Medication-Assisted Treatment (MAT) for
Opioid Use Disorder (OUD) held a 1.5-day workshop in Washington, DC. To support the …

Background The opioid epidemic is a public health crisis. Medications for opioid use
disorder (MOUD) include: 1) buprenorphine, 2) methadone, and 3) extended-release …

Objectives To update the existing evidence to identify specific barriers to initiation of opioid
substitution therapy (OST) for those with opioid use disorder (OUD). Methods The review …

People in the US criminal justice system experience high rates of opioid use disorder,
overdose, and other adverse outcomes. Expanding treatment is a key strategy for …

Background: Policies aimed at addressing the high rates of opioid overdose have prioritized
increasing access to medications for treatment of opioid use disorder (MOUD). Numerous …

Post-release opioid-related overdose mortality is the leading cause of death among people
released from jails or prisons (PRJP). Informed by the proximate determinants framework …

Background and aims Opioid overdose is a leading cause of death during the immediate
time after release from jail or prison. Most jails in the United States do not provide …

Background Opioid use disorder (OUD) is highly prevalent among justice-involved
individuals. While risk for overdose and other adverse consequences of opioid use are …